Jon Napitupulu

Fulgent Pharma, a subsidiary of Fulgent Genetics, presented data at ASCO 2024 showing promising results for their therapeutic candidate,...

Neurogene Inc.’s NGN-401 gene therapy for Rett syndrome has been selected for the FDA’s Support for Clinical Trials Advancing...

Calidi Biotherapeutics presented its latest developments in antitumor virotherapy at the American Society of Clinical Oncology (ASCO) Annual Meeting....

A Phase 2b trial has demonstrated significant improvements for TAK-861, an investigational treatment for narcolepsy type 1 (NT1). The...

Summit Therapeutics raised $200 million through an institutional investment, with shares sold at a premium to the previous closing...

Thermo Fisher Scientific’s new facility in Bleiswijk, Netherlands, offers comprehensive cold and ultra-cold storage services for clinical trials and...

Incyte has strengthened its Inflammation and Autoimmunity pipeline by acquiring Escient Pharmaceuticals. The acquisition brings EP262 and EP547, two...

Paige, a digital pathology and AI leader, has introduced a service line powered by its Foundation Models. These models...

Heart failure, which affects 90,000 Irish citizens, poses a significant burden on healthcare systems. Dublin-based FIRE1 has made a...

Bristol Myers Squibb has garnered FDA approval for Breyanzi, a CAR-T cell therapy for relapsed or refractory mantle cell...